Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (921-930 of 1,920) with videos related to

Pageof 192
Sort By:
RMD Open|April 10, 2026
Spinal mobility and functional limitations in patients with diffuse idiopathic skeletal hyperostosis compared to healthy controls and patients with axial spondyloarthritisDavid Kiefer, Benedikt Eisenbach, Imke Redeker, et al.
RMD Open|June 5, 2025
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodiesMarie Robert, Yann Nguyen, Yves Allenbach, et al.
RMD Open|April 28, 2026
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohortMarie Hornez, Anna Molto, Maxime Leroy, et al.
RMD Open|May 28, 2026
Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritisIsabell S Nevins, Joy Ardjuna van der Pol, Lotte Van Ouwerkerk, et al.
RMD Open|May 13, 2026
Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extensionVictoria Navarro-Compán, Uta Kiltz, Philip J Mease, et al.
RMD Open|May 13, 2026
Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world studyElodie Fels, Cassandra Goncalves, Sandrine Jousse-Joulin, et al.
RMD Open|May 21, 2026
Potential stratification of TAFRO syndrome by anti-SS-A antibodies status and therapeutic response to rituximabTomohiro Suzuki, Saeko Yamada, Kanto Toriumi, et al.
RMD Open|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitisWalter P Maksymowych, Anusha Yeshokumar, Elizabeth Cerullo, et al.
RMD Open|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J)Yoshiya Tanaka, Kentaro Hanami, Yusuke Miyazaki, et al.
RMD Open|October 29, 2023
Sex-specific diagnostic efficacy of MRI in axial spondyloarthritis: challenging the 'One Size Fits All' notionSevtap Tugce Ulas, Fabian Proft, Torsten Diekhoff, et al.
Pageof 192

Showing results (921-930 of 1,920) with videos related to

Sort By:
Pageof 192
RMD Open|April 10, 2026
Spinal mobility and functional limitations in patients with diffuse idiopathic skeletal hyperostosis compared to healthy controls and patients with axial spondyloarthritisDavid Kiefer, Benedikt Eisenbach, Imke Redeker, et al.
RMD Open|June 5, 2025
Cluster analysis identifies three clinical patterns of patients with systemic autoimmune diseases and anti-Ku antibodiesMarie Robert, Yann Nguyen, Yves Allenbach, et al.
RMD Open|April 28, 2026
Impact of postpartum on patients with rheumatoid arthritis and spondyloarthritis: an ancillary analysis of the GR2 prospective cohortMarie Hornez, Anna Molto, Maxime Leroy, et al.
RMD Open|May 28, 2026
Induction of Cure in Early Arthritis (I CEA): results of a randomised clinical trial to compare three treatment strategies in recent onset undifferentiated arthritisIsabell S Nevins, Joy Ardjuna van der Pol, Lotte Van Ouwerkerk, et al.
RMD Open|May 13, 2026
Bimekizumab treatment for sustained improvements in patient symptoms and health-related quality of life to 3 years in axial spondyloarthritis: results from the BE MOBILE studies and their open-label extensionVictoria Navarro-Compán, Uta Kiltz, Philip J Mease, et al.
RMD Open|May 13, 2026
Relapse risk of lupus-related serositis according to immunosuppressive therapy: a national real-world studyElodie Fels, Cassandra Goncalves, Sandrine Jousse-Joulin, et al.
RMD Open|May 21, 2026
Potential stratification of TAFRO syndrome by anti-SS-A antibodies status and therapeutic response to rituximabTomohiro Suzuki, Saeko Yamada, Kanto Toriumi, et al.
RMD Open|May 21, 2026
Phase II randomised, placebo-controlled study to evaluate the efficacy and safety of an MK2 inhibitor in ankylosing spondylitisWalter P Maksymowych, Anusha Yeshokumar, Elizabeth Cerullo, et al.
RMD Open|May 12, 2026
Real-world effectiveness, safety and patient-reported outcomes of sarilumab in patients with rheumatoid arthritis: a 52-week, prospective, open-label, non-interventional, observational, nationwide, large-cohort study in Japan (PROFILE-J)Yoshiya Tanaka, Kentaro Hanami, Yusuke Miyazaki, et al.
RMD Open|October 29, 2023
Sex-specific diagnostic efficacy of MRI in axial spondyloarthritis: challenging the 'One Size Fits All' notionSevtap Tugce Ulas, Fabian Proft, Torsten Diekhoff, et al.
Pageof 192